Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cerenis Therapeutics brings in €25mm with its Series A round

Executive Summary

Cerenis Therapeutics SA (cardiovascular and metabolic drugs) has raised €25mm ($30.4mm) with its Series A venture round. Co-lead investors Sofinnova Partners and HealthCap were joined by Alta Partners, EDF Ventures, and NIF Ventures.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies